CHRND Antikörper (C-Term)
Kurzübersicht für CHRND Antikörper (C-Term) (ABIN347261)
Target
Alle CHRND Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- C-Term
-
Spezifität
- Reacts with human CHRND protein
-
Kreuzreaktivität
- Maus, Ratte (Rattus)
-
Kreuzreaktivität (Details)
- Cross reacts with protein from mouse, rat and other species due to sequence homology.
-
Aufreinigung
- Antiserum
-
Immunogen
- Synthetic peptide derived from C-term domain of the human CHRND protein.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
Working dilution: Optimal dilution should be determined by the end user.
The following are guidelines only :
IF(1:100 - 1:500) WB(1:500 - 1:5000) -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Must be reconstituted in distilled water.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Lyophilized powder stable for a minimum of 2 years at -20°C. Store reconstituted antibodies at +4°C. For extended periods store in aliquots at -20°C. Antibodies are guaranteed for 6 month from date of receipt.
-
Haltbarkeit
- 24 months
-
-
- CHRND (Cholinergic Receptor, Nicotinic, delta (Muscle) (CHRND))
-
Andere Bezeichnung
- Acetylcholine Receptor Protein, delta Subunit (CHRND)
-
Hintergrund
- Belongs to the ligand-gated ion channel family. Acetylcholine receptor subfamily. Delta/CHRND sub-subfamily. Defects in CHRND are a cause of multiple pterygium syndrome lethal type (MUPSL), congenital myasthenic syndrome slow-channel type (SCCMS) and congenital myasthenic syndrome fast-channel type (FCCMS).
-
UniProt
- Q07001
Target
-